PNC Financial Services Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
EA
EMFAT
PNC Financial Services Group's COGT Position: Q2 2026 in Review
PNC Financial Services Group increased its Cogent Biosciences (COGT) stake by 32% in Q2 2026, buying an estimated $16.1K and bringing the position to 1,893 shares worth $73.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.
PNC Financial Services Group first reported a position in COGT in Q4 2023 and has held it in 11 quarters since. 101 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- PNC Financial Services Group held 1,893 shares of Cogent Biosciences worth $73.3K as of Q2 2026.
- PNC Financial Services Group bought 460 Cogent Biosciences shares in Q2 2026, an estimated $16.1K.
- Cogent Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3114 holding.
- PNC Financial Services Group first reported a position in Cogent Biosciences in Q4 2023 and has held it in 11 quarters since.
- 101 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.